1. Home
  2. STEL vs NNNN Comparison

STEL vs NNNN Comparison

Compare STEL & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stellar Bancorp Inc.

STEL

Stellar Bancorp Inc.

HOLD

Current Price

$30.73

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$29.48

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STEL
NNNN
Founded
2007
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
STEL
NNNN
Price
$30.73
$29.48
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$31.33
N/A
AVG Volume (30 Days)
266.7K
37.2K
Earning Date
01-29-2026
04-28-2026
Dividend Yield
1.95%
N/A
EPS Growth
N/A
N/A
EPS
1.94
0.06
Revenue
$416,539,000.00
$6,920,153.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.41
N/A
P/E Ratio
$15.86
$502.67
Revenue Growth
N/A
N/A
52 Week Low
$24.13
$5.18
52 Week High
$32.74
$55.65

Technical Indicators

Market Signals
Indicator
STEL
NNNN
Relative Strength Index (RSI) 41.30 47.83
Support Level $31.16 $31.18
Resistance Level $31.14 $38.00
Average True Range (ATR) 0.60 3.72
MACD -0.19 -0.50
Stochastic Oscillator 10.80 28.64

Price Performance

Historical Comparison
STEL
NNNN

About STEL Stellar Bancorp Inc.

Stellar Bancorp Inc is a U.S. based bank holding company. Through its subsidiary, Stellar Bank, the company provides a diversified range of commercial banking services predominantly to small to medium sized businesses, professionals, and individual customers. Its offerings include different types of loans, such as mortgage loans, home equity loans, automobile loans, etc.; deposit products, such as checking accounts, commercial accounts, money market accounts, savings accounts, etc.; and other banking services like mobile banking, debit cards, cash management and wire transfer services, letters of credit, and others.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: